Can levothyroxine and pantoprazole be taken at the same time?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, levothyroxine and pantoprazole should NOT be taken at the same time

Pantoprazole significantly reduces levothyroxine absorption and should be separated from levothyroxine administration by at least 4 hours, or ideally taken at different times of day (levothyroxine in the morning, pantoprazole in the evening).

The Drug Interaction Problem

The FDA drug label for pantoprazole explicitly warns that proton pump inhibitors (PPIs) can reduce the absorption of drugs dependent on gastric pH, including levothyroxine 1. This is not a theoretical concern—multiple high-quality observational studies demonstrate clinically significant effects:

  • A large population study of nearly 11,000 levothyroxine-treated patients found that PPIs increased serum TSH by 0.12 mU/L on average, with 5.6% of patients experiencing a clinically significant TSH increase of over 5 mU/L 2
  • An Italian general practice study of 5,426 patients showed that co-prescription of levothyroxine with PPIs resulted in increased levothyroxine prescriptions and higher doses needed to maintain thyroid control 3
  • A prospective crossover study specifically examining pantoprazole demonstrated significant TSH elevation in levothyroxine-treated patients after just 6 weeks of concomitant use, regardless of whether pantoprazole was taken in the morning or evening 4

Why This Happens

PPIs like pantoprazole increase gastric pH, which impairs the dissolution and absorption of levothyroxine tablets. The effect is substantial enough that patients often require 25-50 mcg higher levothyroxine doses when taking PPIs chronically 5.

Practical Management Strategies

Option 1: Separate Administration Times (Preferred)

  • Take levothyroxine first thing in the morning on an empty stomach (30-60 minutes before breakfast)
  • Take pantoprazole in the evening, 30 minutes before dinner
  • This provides maximum separation (approximately 12 hours) and minimizes the interaction 4

Option 2: Use Alternative Levothyroxine Formulations

  • Liquid levothyroxine formulations (Tirosint-SOL) are minimally affected by PPIs and can be taken simultaneously without significant interaction 6
  • Soft gel capsule formulations show better absorption than tablets when PPIs are used, with faster Tmax (120 vs 180 minutes) and higher AUC 5
  • If switching to these formulations, expect to need 25-50 mcg LESS levothyroxine than the tablet dose 5

Option 3: Consider Alternative Acid Suppression

  • H2 receptor antagonists do not significantly affect levothyroxine absorption 2
  • However, they are less effective than PPIs for most indications requiring acid suppression

Monitoring Requirements

When pantoprazole must be used with levothyroxine:

  • Check TSH 6-8 weeks after starting or stopping pantoprazole 7, 8
  • Monitor TSH every 6 weeks during the first 6 months of concomitant therapy 4
  • Once stable, check TSH every 6-12 months 7
  • Be prepared to increase levothyroxine dose by 25-50 mcg if TSH rises above target 5, 3

Critical Pitfalls to Avoid

  1. Don't assume the interaction is minor: 5-8% of patients experience clinically significant TSH elevations requiring dose adjustments 2, 3

  2. Don't rely on "taking them a few minutes apart": The interaction is due to sustained elevation of gastric pH, not just immediate timing. Separation of at least 4 hours is needed, though 12 hours is better 4

  3. Don't forget to recheck TSH when stopping the PPI: Levothyroxine requirements will decrease, potentially causing iatrogenic hyperthyroidism if the dose isn't reduced 3

  4. Don't switch levothyroxine brands or formulations without monitoring: Bioavailability varies significantly between tablet, liquid, and soft gel formulations, especially in the presence of PPIs 5, 9

The evidence consistently shows that simultaneous administration compromises levothyroxine effectiveness. While the interaction can be managed through timing separation or formulation changes, taking them together at the same time should be avoided.

References

Research

Tablet levothyroxine (L-T4) malabsorption induced by proton pump inhibitor; a problem that was solved by switching to L-T4 in soft gel capsule.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2014

Research

Proton Pump Inhibitors Do Not Affect the Bioavailability of a Novel Liquid Formulation of Levothyroxine.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2024

Guideline

clinical practice guidelines for hypothyroidism in adults: cosponsored by the american association of clinical endocrinologists and the american thyroid association.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2012

Related Questions

Can taking levothyroxine (Synthroid) 50 µg and then pantoprazole 30 minutes later affect their efficacy, and how should they be timed if both must be taken 30 minutes before food?
Should levothyroxine (synthetic thyroxine) and Lip‑thyroxin (levothyroxine) be prescribed together?
How long after taking Tirosint (levothyroxine) solution should I take Pepcid (famotidine)?
What is the recommended interval between taking levothyroxine (Synthroid) and a glucocorticoid (e.g., prednisone)?
How to manage hypothyroidism in a patient taking Protonix (pantoprazole), a Proton Pump Inhibitor (PPI)?
What is the normal length of the labia majora in adult females?
In a 29-year-old male on lisinopril 20 mg whose blood pressure remains in the 130/80 mm Hg range, what is the recommended management?
For a 45-year-old premenopausal woman with a 1.8 cm grade 1 hormone‑receptor‑positive, HER2‑negative, node‑negative invasive ductal carcinoma and a Recurrence Score of 18 who has completed four cycles of docetaxel‑carboplatin (TC) chemotherapy, what is the recommended adjuvant therapy?
Should a 45-year-old premenopausal woman with a 1.8 cm grade 1 hormone‑receptor‑positive, HER2‑negative, node‑negative invasive ductal carcinoma, Recurrence Score 18, who has already completed four cycles of docetaxel‑carboplatin, be given additional chemotherapy?
What does autofusion of the proximal interphalangeal (PIP) joint mean in plain terms?
For a 45-year-old premenopausal woman with a 1.8 cm grade 1 hormone‑receptor‑positive, HER2‑negative, node‑negative invasive ductal carcinoma and a Recurrence Score of 18, is four cycles of adjuvant docetaxel‑cyclophosphamide (TC) the appropriate chemotherapy regimen?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.